Strategic Partnering: Transformational Change in R&D Outsourcing

De cember 16 , 2009 ♦ 11:00 a.m. EST Presented By John Watson, president, Strategic Partnering & Integrated Drug Development, Covance Joshua L. Smiley, VP & CFO, Lilly Research Laboratories, Eli Lilly & Co. The biopharmaceutical industry is experiencing a paradigm shift as new models for drug development emerge alongside an evolving CRO industry. An approaching patent cliff and financial/regulatory pressures at all-time highs has fueled the biggest trend in drug development outsourcing -- strategic partnering. The move from highly transactional relationships to trust-based, innovative partnerships is creating value for the biopharmaceutical industry by improving R&D productivity. Join us for this complimentary 60 minute eBroadcast as executives from Covance and Eli Lilly discuss how strategic partnering can improve R&D productivity. Participants will learn: The evolution of contemporary CROs Innovative solutions for more efficient R&D How an asset transfer worked for Eli Lilly Partnerships fuel the future of outsourcing http://www.frost.com/prod/servlet/ebroadcast.pag?eventid=182465980